相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?
Gyorgy Baffy et al.
JOURNAL OF HEPATOLOGY (2022)
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis
Jose Ferrusquia-Acosta et al.
JOURNAL OF HEPATOLOGY (2021)
Extracellular vesicles in hepatology: Physiological role,involvement in pathogenesis, and therapeutic opportunities
Maria Azparren-Angulo et al.
PHARMACOLOGY & THERAPEUTICS (2021)
The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis
Vicente Arroyo et al.
JOURNAL OF HEPATOLOGY (2021)
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Jason Behary et al.
NATURE COMMUNICATIONS (2021)
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Pierre-Antoine Soret et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The Power of Plasticity?Metabolic Regulation of Hepatic Stellate Cells
Parth Trivedi et al.
CELL METABOLISM (2021)
Heterogeneity of HSCs in a Mouse Model of NASH
Sara Brin Rosenthal et al.
HEPATOLOGY (2021)
Role of liver sinusoidal endothelial cells in liver diseases
Jordi Gracia-Sancho et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives
Kristoffer Kjaergaard et al.
JOURNAL OF CLINICAL MEDICINE (2021)
PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease
Maria E. Moreno-Fernandez et al.
CELL METABOLISM (2021)
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Roser Pinyol et al.
JOURNAL OF HEPATOLOGY (2021)
Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications
Qianqian Xu
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister et al.
NATURE (2021)
Metabolic-associated fatty liver disease and lipoprotein metabolism
Joerg Heeren et al.
MOLECULAR METABOLISM (2021)
Liver Zonation - Revisiting Old Questions With New Technologies
Rory P. Cunningham et al.
FRONTIERS IN PHYSIOLOGY (2021)
Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
Olga Estevez-Vazquez et al.
BIOMEDICINES (2021)
Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease?
Esperanza Gonzalez et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
NASH-related increases in plasma bile acid levels depend on insulin resistance
Guillaume Grzych et al.
JHEP REPORTS (2021)
An Experimental DUAL Model of Advanced Liver Damage
Raquel Benede-Ubieto et al.
HEPATOLOGY COMMUNICATIONS (2021)
Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature
Ana Garcia Garcia de Paredes et al.
HEPATOLOGY COMMUNICATIONS (2021)
Human Nonalcoholic Steatohepatitis on a Chip
May S. Freag et al.
HEPATOLOGY COMMUNICATIONS (2021)
Organoids to model liver disease
Sandro Nuciforo et al.
JHEP REPORTS (2021)
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister et al.
NATURE (2021)
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Richard Moreau et al.
JOURNAL OF HEPATOLOGY (2020)
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo et al.
CELL METABOLISM (2020)
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
Jorge Simon et al.
CELL METABOLISM (2020)
Albumin in decompensated cirrhosis: new concepts and perspectives
Mauro Bernardi et al.
GUT (2020)
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Javier Ampuero et al.
JOURNAL OF HEPATOLOGY (2020)
The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management
Genoveva Berna et al.
LIVER INTERNATIONAL (2020)
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Nonalcoholic Steatohepatitis: A Review
Adam C. Sheka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epitranscriptomics in liver disease: Basic concepts and therapeutic potential
Zhicong Zhao et al.
JOURNAL OF HEPATOLOGY (2020)
Animal models for liver disease - A practical approach for translational research
Yulia A. Nevzorova et al.
JOURNAL OF HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients
Isabel Gomez-Hurtado et al.
LIVER INTERNATIONAL (2020)
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
Lucia Barbier-Torres et al.
NATURE COMMUNICATIONS (2020)
The role of stress kinases in metabolic disease
Ivana Nikolic et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Cell Death in Liver Diseases: A Review
Layla Shojaie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
Olivier Govaere et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Uncovering the Role of p38 Family Members in Adipose Tissue Physiology
Magdalena Leiva et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Stress kinases in the development of liver steatosis and hepatocellular carcinoma
Beatriz Cicuendez et al.
MOLECULAR METABOLISM (2020)
Genetic and epigenetic factors determining NAFLD risk
Wenke Jonas et al.
MOLECULAR METABOLISM (2020)
Nuclear deformation mediates liver cell mechanosensing in cirrhosis
Sergi Guixe-Muntet et al.
JHEP REPORTS (2020)
Crohn's Disease Is Associated With an Increased Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Magnetic Resonance Proton Density Fat Fraction Mapping
Scott McHenry et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
Oscar Chavez-Talavera et al.
CURRENT OPINION IN LIPIDOLOGY (2019)
Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells
Hai-xia Yu et al.
MOLECULAR IMMUNOLOGY (2019)
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Cyrielle Caussy et al.
NATURE COMMUNICATIONS (2019)
The molecular machinery of regulated cell death
Daolin Tang et al.
CELL RESEARCH (2019)
A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices
Hannah L. Paish et al.
HEPATOLOGY (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document
Paolo Angeli et al.
JOURNAL OF HEPATOLOGY (2019)
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Chiara Rosso et al.
JOURNAL OF HEPATOLOGY (2019)
High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors
C. Duran-Vian et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
A standardised framework to identify optimal animal models for efficacy assessment in drug development
Guilherme S. Ferreira et al.
PLOS ONE (2019)
Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease
Barham K. Abu Dayyeh et al.
JOURNAL OF HEPATOLOGY (2019)
New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease
Raquel Maeso-Diaz et al.
CELLS (2019)
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk et al.
EMBO MOLECULAR MEDICINE (2019)
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell et al.
HEPATOLOGY (2019)
Hepatic microcirculation and mechanisms of portal hypertension
Jordi Gracia-Sancho et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Justin A. Fletcher et al.
JCI INSIGHT (2019)
Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
Matthew J. Klebanoff et al.
JAMA NETWORK OPEN (2019)
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
Sander Lefere et al.
JHEP REPORTS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors
F. Tovoli et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease
Gyorgy Baffy
DIGESTIVE DISEASES AND SCIENCES (2018)
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Veeral Ajmera et al.
GASTROENTEROLOGY (2018)
Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials
Cyrielle Caussy et al.
HEPATOLOGY (2018)
The nutritional geometry of liver disease including non-alcoholic fatty liver disease
Stephen J. Simpson et al.
JOURNAL OF HEPATOLOGY (2018)
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan et al.
JOURNAL OF HEPATOLOGY (2018)
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization
Yanmei Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
Sonya A. MacParland et al.
NATURE COMMUNICATIONS (2018)
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail
Pandora Pound et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2017)
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
Vanessa Legry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero-Gómez et al.
JOURNAL OF HEPATOLOGY (2017)
Epigenetics in non-alcoholic fatty liver disease
Jooho Lee et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Inflammation, metaflammation and immunometabolic disorders
Gokhan S. Hotamisligil
NATURE (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism
Felix Royo et al.
SCIENTIFIC REPORTS (2017)
Bile Acids in Physiology, Pathology and Pharmacology
Jose J. G. Marin et al.
CURRENT DRUG METABOLISM (2016)
Nutritional Ecology and Human Health
David Raubenheimer et al.
ANNUAL REVIEW OF NUTRITION, VOL 36 (2016)
Sinusoidal communication in liver fibrosis and regeneration
Giusi Marrone et al.
JOURNAL OF HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
OBESITY FACTS (2016)
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
Chrysi Koliaki et al.
CELL METABOLISM (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Sorting signal targeting mRNA into hepatic extracellular vesicles
Natalia Szostak et al.
RNA BIOLOGY (2014)
Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease
Nishanth E. Sunny et al.
CELL METABOLISM (2011)
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients
Esther Zimmermann et al.
JOURNAL OF HEPATOLOGY (2011)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)